Case report demonstrates the potential of immunotherapy in pulmonary sarcomatoid carcinoma, suggesting genetic testing is crucial for treatment decisions.
For patients with PSC, genetic testing is necessary. The efficacy of immunotherapy in patients with PSC is worthy of expectation.
No takes yet. Share an insight, caveat, or question.
Ouyang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: